WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2007009320) A PREPARATION OF STATINS FOR PROLONGED RELEASE
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2007/009320    International Application No.:    PCT/CN2005/001967
Publication Date: 25.01.2007 International Filing Date: 21.11.2005
IPC:
A61K 9/70 (2006.01), A61K 47/00 (2006.01), A61K 31/22 (2006.01)
Applicants: PFICKER PHARMACEUTICALS LTD. [CN/CN]; Floor 6, Gongshang Building, Huili Road, Huaibei, Anhui 235000 (CN) (For All Designated States Except US).
YIE, Hongping [CN/CN]; (CN) (For US Only).
ZHU, Zuolin [US/US]; (US) (For US Only).
SUN, Meg M. [US/US]; (US) (For US Only)
Inventors: YIE, Hongping; (CN).
ZHU, Zuolin; (US).
SUN, Meg M.; (US)
Agent: SHANGHAI PATENT & TRADEMARK LAW OFFICE, LLC; XU, Xun, 435 Guiping Road, Shanghai 200233 (CN)
Priority Data:
200510085860.0 19.07.2005 CN
Title (EN) A PREPARATION OF STATINS FOR PROLONGED RELEASE
(FR) PRÉPARATION DE STATINES POUR LIBÉRATION PROLONGÉE
(ZH) 他汀类药物的长效制剂
Abstract: front page image
(EN)A preparation of statins for prolonged release. The preparation is a transdermal therapeutic system or hypodermic implantation system. And they overcome the problem of low bioavailability and increase patient compliance. The statins in the invention contain all of statins and responding salts, hydroxyl ester derivatives at 4-position. The invention has many advantages: for example, reduce dosage frequency, remain stable and lasting blood concentration of medicine, further improve the curative effect, providepatients with a convenient and safety means of administration, and obtain an effective period of up to seven days to months by taking medicine once.
(FR)L’invention a pour objet une préparation de statines pour libération prolongée. La préparation est un système thérapeutique transdermique ou un système d'implantation hypodermique qui résout le problème de faible biodisponibilité et augmente l’assiduité du patient. Les statines de l'invention contiennent toutes les statines, les correspondants sels, et les dérivés de l'hydroxyl ester en position 4. L'invention a beaucoup d'avantages : par exemple, elle réduit la fréquence de dosage, maintient la concentration stable et durable de médicament dans le sang, améliore encore l'effet curatif, fournit aux patients un moyen d'administration aisé et sûr, et permet d’obtenir une période efficace de sept jours jusqu'à plusieurs mois en ne prenant le médicament qu’une fois.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, LY, MA, MD, MG, MK, MN, MW, MX, MZ, NA, NG, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RU, SC, SD, SE, SG, SK, SL, SM, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, YU, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LT, LU, LV, MC, NL, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: Chinese (ZH)
Filing Language: Chinese (ZH)